Amgen Inc. (LON:0R0T)

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of GBP 149.73 billion. The enterprise value is 184.05 billion.

Market Cap	149.73B
Enterprise Value	184.05B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Feb 13, 2026

Share Statistics

Current Share Class	539.07M
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	537.72M

Valuation Ratios

The trailing PE ratio is 26.13 and the forward PE ratio is 16.72.

PE Ratio	26.13
Forward PE	16.72
PS Ratio	5.48
PB Ratio	23.28
P/TBV Ratio	n/a
P/FCF Ratio	24.88
P/OCF Ratio	20.24
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.72, with an EV/FCF ratio of 30.58.

EV / Earnings	32.12
EV / Sales	6.76
EV / EBITDA	14.72
EV / EBIT	21.46
EV / FCF	30.58

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.40.

Current Ratio	1.14
Quick Ratio	0.73
Debt / Equity	6.40
Debt / EBITDA	3.29
Debt / FCF	6.84
Interest Coverage	3.66

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.12%.

Return on Equity (ROE)	106.10%
Return on Assets (ROA)	7.93%
Return on Invested Capital (ROIC)	18.12%
Return on Capital Employed (ROCE)	17.78%
Weighted Average Cost of Capital (WACC)	6.33%
Revenue Per Employee	866,857
Profits Per Employee	181,882
Employee Count	31,500
Asset Turnover	0.40
Inventory Turnover	1.62

Taxes

In the past 12 months, Amgen has paid 939.90 million in taxes.

Income Tax	939.90M
Effective Tax Rate	14.09%

Stock Price Statistics

The stock price has increased by +27.50% in the last 52 weeks. The beta is 0.45, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+27.50%
50-Day Moving Average	340.80
200-Day Moving Average	306.72
Relative Strength Index (RSI)	63.01
Average Volume (20 Days)	1,953

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.59

Income Statement

In the last 12 months, Amgen had revenue of GBP 27.31 billion and earned 5.73 billion in profits. Earnings per share was 10.57.

Revenue	27.31B
Gross Profit	19.33B
Operating Income	8.60B
Pretax Income	6.67B
Net Income	5.73B
EBITDA	12.35B
EBIT	8.60B
Earnings Per Share (EPS)	10.57

Balance Sheet

The company has 6.78 billion in cash and 41.19 billion in debt, with a net cash position of -34.41 billion.

Cash & Cash Equivalents	6.78B
Total Debt	41.19B
Net Cash	-34.41B
Net Cash Per Share	n/a
Equity (Book Value)	6.43B
Book Value Per Share	11.94
Working Capital	2.65B

Cash Flow

In the last 12 months, operating cash flow was 7.40 billion and capital expenditures -1.38 billion, giving a free cash flow of 6.02 billion.

Operating Cash Flow	7.40B
Capital Expenditures	-1.38B
Free Cash Flow	6.02B
FCF Per Share	n/a

Margins

Gross margin is 70.78%, with operating and profit margins of 31.49% and 20.98%.

Gross Margin	70.78%
Operating Margin	31.49%
Pretax Margin	24.42%
Profit Margin	20.98%
EBITDA Margin	45.22%
EBIT Margin	31.49%
FCF Margin	22.04%

Dividends & Yields

This stock pays an annual dividend of 7.22, which amounts to a dividend yield of 1.93%.

Dividend Per Share	7.22
Dividend Yield	1.93%
Dividend Growth (YoY)	0.46%
Years of Dividend Growth	7
Payout Ratio	66.45%
Buyback Yield	-0.19%
Shareholder Yield	1.74%
Earnings Yield	3.83%
FCF Yield	4.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.65
Piotroski F-Score	7